Villeurbanne, France

Luc Denoroy

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Cpe Lyon Fcr, Institut National Des Sciences Appliquees De Lyon. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luc Denoroy. Retrieved from https://idiyas.com/inventor/luc-denoroy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luc Denoroy: Innovator in Pyrrolidine Derivatives

Introduction

Luc Denoroy is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of pharmaceuticals, particularly through his work on pyrrolidine derivatives. His innovative approach has the potential to impact the treatment of various neurological and psychiatric conditions.

Latest Patents

Denoroy holds a patent for novel pyrrolidine derivatives, which are described by a specific formula. These compounds can exist in various forms, including zwitterionic forms, pure optical isomers, or mixtures of optical isomers. They are particularly useful in treating conditions such as epilepsy, ischemia, and neurodegenerative diseases like Parkinson's disease and Alzheimer's disease. The patent also covers their pharmaceutically acceptable salts, solvates, or hydrates, as well as pharmaceutical compositions containing these compounds.

Career Highlights

Throughout his career, Luc Denoroy has worked with esteemed institutions such as Université Claude Bernard Lyon I and Institut National des Sciences Appliquées de Lyon. His research has focused on developing innovative solutions for complex medical challenges, showcasing his dedication to advancing pharmaceutical science.

Collaborations

Denoroy has collaborated with notable colleagues, including Jean-Pierre Praly and Kaiss Aouadi. These partnerships have enriched his research and contributed to the development of his patented compounds.

Conclusion

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…